Publication | Open Access

A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma

Gastrointestinal OncologyMedicineGastroenterologyPathologyPhase Ii StudyRaltitrexed Combination ChemotherapyCancer TreatmentGastric AdenocarcinomaOncologyRadiation Oncology